• IMAB

Earnings call: I-MAB Biopharma discusses pipeline progress and financials

I-MAB Biopharma discusses its focus on oncology drug development, financial health, and strategic restructuring during a recent earnings call, highlighting promising pipeline candidates and upcoming milestones.